Fundamentals

Valuation

Metric	Q1	Q3	Δ in %
EV/EBITDA	-95.07	163.82	-3325.87
Graham Fair Price	417.89	3.54	0.68
PEG	-92.42	-0.77	10.10
Price/Book	-4.70	3.02	3.17
Price/Cash Flow	399.27	170.71	-34.19
Prices/Earnings	-96.27	38.29	-1026.88
Price/Sales	-60.27	16.11	40.55
Price/FCF	399.27	170.71	-34.19
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q3	Δ in %
Gross Profit Margin	-15.81	0.17	0.21
Operating Margin	138.87	0.10	-0.04
ROA	2378.20	0.01	< 0.005
ROE	< 0.005	0.02	2455.59
ROIC	< 0.005	0.02	421.29
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q3	Δ in %
Debt QOQ	-0.48	0.15	223.68
Dividends QOQ	-0.69	59.64	8532.04
EBIT QOQ	-1.07	-0.24	77.91
EPS QOQ	-1.02	-0.50	50.82
FCF QOQ	-1.79	1.27	-28.66
Revenue QOQ	-0.78	-0.21	72.32
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	463.77	189.96	-59.04
Days Sales Outstanding (DSO)	831.45	333.30	-59.91
Inventory Turnover	0.19	0.47	144.14
Debt/Capitalization	0.07	0.14	118.78
Quick Ratio	1.20	1.23	3.06
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q3	Δ in %
Book Value	5.18	5.31	2.44
Cash	0.20	0.32	58.89
Capex	-0.02	0.03	35.81
Free Cash Flow	-0.48	0.09	-80.45
Revenue	0.41	1.00	145.72
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q3	Δ in %
Current Ratio	1.70	1.72	0.96
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-31.40	5.66	-81.98
Naive Interpretation	Member

06 - Financial Health · Weak

Rating